Assertio Holdings (ASRT) Deferred Taxes (2022 - 2023)
Assertio Holdings' (ASRT) quarterly Deferred Taxes came in at $29.0 million in Q4 2023, up 136.09% year-on-year from $12.3 million in Q4 2022, and down 40.28% quarter-over-quarter from $48.6 million in Q3 2023.
Assertio Holdings (ASRT) Deferred Taxes (2022 - 2023) Analysis & Trends
Assertio Holdings has disclosed Deferred Taxes across 2 years of filings, most recently posting $29.0 million for Q4 2023.
- Deferred Taxes for Q4 2023 came in at $29.0 million, up 136.09% year-over-year; the trailing twelve-month figure through Sep 2024 was $29.0 million (up 187.42% YoY), and the FY2023 annual result was $76.2 million, up 194.81% from the prior year.
- Deferred Taxes came in at $29.0 million for Q4 2023 at Assertio Holdings, down from $48.6 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $48.6 million in Q3 2023 to a low of -$80.4 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -22.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 34.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 25.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 14,341.73 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -61.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -8.79 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -13.98 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 19.33 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 29.01 Mn |
| Sep 30, 2023 | 48.58 Mn |
| Jun 30, 2023 | -18,000.00 |
| Mar 31, 2023 | -1.37 Mn |
| Dec 31, 2022 | -80.38 Mn |